TorreyPines Therapeutics Lops Employees, Looks For Buyer
, a biopharmaceuticals firm focused on small molecule compounds, said this week that it has reduced its work force to just three employees. The firm said the move came as it looks to evaluate strategic alternatives, including a possible sale of the firm. The firm said its CEO, CFO, and VP/General Counsel remain to assist the firm's board in strategic transactions.
posted on Thursday, April 2, 2009
> TorreyPines Therapeutics Hires Investment Banker
> Metabasis Therapeutics Lops 85 Percent , Looks For Buyer
> Metabasis Therapeutics Lops 43 Percent
> MySpace Lops 300 International Employees
> Adventrx Reaches End Of Line, Looks For Buyer